Detalle de: Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique
| Title | Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique |
| Abstract |
Multidrug-resistant(MDR) tuberculosis in Southern Africa is of great concern, exacerbated by the spread of a clone harboring a mutation missed by Xpert Ultra. In Southern Mozambique, the presence of such mutation and rising cases of non-MDR isoniazid resistance highlights the need to ensure accurate detection of antimicrobial-resistance in the country. |
| Apa Reference | Mariner-Llicer, C., Saavedra Cervera, B., Mambuque, E., Gomes, N., Munguambe, S., Villamayor, L., Cancino-Muñoz, I., Torres-Puente, M., Nguenha, D., Respeito, D., Tembe, G., López, M.G., Comas, I. & García-Basteiro, A.L. (2023). Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique. Clinical Infectious Diseases, 78(4), 842-845. 10.1093/cid/ciad684 |
| Doi | 10.1093/cid/ciad684 |
| Publication Date | 4 Dec 2023 |
| Publication Type | Article |
| Researcher | Iñaki Comas Espadas |
| Ontology | Mutation Analysis and design, Drug resistance |
| Research Groups | |
| Tools |